Not applicableStudy completedNCT00454077What this trial is testingRhTSH-Thyroid Ablation With 1850 MBq of 131IWho this might be right forThyroid Cancer University of Siena 72
Large-scale testing (Phase 3)UnknownNCT00415233What this trial is testingHigh Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid CancerWho this might be right forHead and Neck Cancer University College, London 438
Post-approval studies (Phase 4)Study completedNCT00001730What this trial is testingStudy of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.Who this might be right forHypothyroidismThyroid Neoplasms National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 20
Not applicableLooking for participantsNCT06431620What this trial is testingSafety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid CancerWho this might be right forRecombinant Human Thyroid Stimulating Hormone Nanjing First Hospital, Nanjing Medical University 15
Large-scale testing (Phase 3)Study completedNCT00295763What this trial is testingA New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.Who this might be right forDifferentiated Thyroid Cancer Genzyme, a Sanofi Company 61
Not applicableStudy completedNCT01736163What this trial is testingA Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 TumoursWho this might be right forThyroid Cancer Genzyme, a Sanofi Company 144
Not applicableEnded earlyNCT00926978What this trial is testingComparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)Who this might be right forThyroid Cancer Medstar Health Research Institute 21
Testing effectiveness (Phase 2)Study completedNCT00454220What this trial is testingStudy to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular GoiterWho this might be right forMultinodular Goiter Genzyme, a Sanofi Company 96
Not applicableStudy completedNCT00439127What this trial is testingOnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine AblationWho this might be right forDifferentiated Thyroid Carcinoma Oncology Institute of Southern Switzerland 28
Testing effectiveness (Phase 2)Ended earlyNCT04873869What this trial is testingStudy to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)Who this might be right forSCN8A Developmental and Epileptic Encephalopathy Syndrome Neurocrine Biosciences 8
Not applicableEnded earlyNCT01412918What this trial is testingInhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene ExpressionWho this might be right forTinnitus Medical College of Wisconsin 21
Large-scale testing (Phase 3)Study completedNCT04964284What this trial is testingRhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC)Who this might be right forDifferentiated Thyroid Cancer Suzhou Zelgen Biopharmaceuticals Co.,Ltd 390
Testing effectiveness (Phase 2)Ended earlyNCT05226780What this trial is testingExtension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEEWho this might be right forSCN8A Developmental and Epileptic Encephalopathy Syndrome Neurocrine Biosciences 8
Testing effectiveness (Phase 2)Study completedNCT01182285What this trial is testingA Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell OriginWho this might be right forThyroid Neoplasm National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT00071838What this trial is testingZenapax (Daclizumab) to Treat Relapsing Remitting Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-Remitting National Institute of Neurological Disorders and Stroke (NINDS) 16
Testing effectiveness (Phase 2)Study completedNCT00275171What this trial is testingRhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular GoiterWho this might be right forNodular Goiter Steen Bonnema 90
Not applicableStudy completedNCT05316987What this trial is testingEffect of NB-UVB on the Tissue Level of IL 15 and IL-15Rα in Active Non Segmental Vitiligo Cases.Who this might be right forActive Non Segmental Vitiligo Cairo University 30
Testing effectiveness (Phase 2)Ended earlyNCT05493293What this trial is testingExtension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset SeizuresWho this might be right forFocal Onset SeizureFocal Onset Epilepsy Neurocrine Biosciences 82
Post-approval studies (Phase 4)Study completedNCT00604318What this trial is testingQuality of Life, Recombinant TSH (Thyrogen) and Thyroid CancerWho this might be right forThyroid Cancer Copenhagen University Hospital at Herlev 56
Testing effectiveness (Phase 2)Study completedNCT00181168What this trial is testingRecombinant Thyrotropin PET-CT Fusion Scanning in Thyroid CancerWho this might be right forThyroid Cancer Johns Hopkins University 63